Novo Nordisk is facing “unprecedented” price pressures, “intensifying competition” and patents expiring.
Wegovy maker warns price cuts ‘painful’ for firm as shares plunge
Novo Nordisk is facing “unprecedented” price pressures, “intensifying competition” and patents expiring.